Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - NET INCOME
Net Income REGN - Regeneron Pharmaceuticals, Inc.
4.41 B
LAST VALUE
0.85%
2 YEAR CAGR
15.84%
5 YEAR CAGR
28.91%
10 YEAR CAGR